Barclays Maintains Overweight on P10, Lowers Price Target to $9.5
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish maintains an Overweight rating on P10 (NYSE:PX) but lowers the price target from $14 to $9.5.

March 04, 2024 | 11:42 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays maintains an Overweight rating on P10 but lowers the price target from $14 to $9.5.
While the maintenance of an Overweight rating suggests a positive outlook on P10's stock, the reduction in the price target could signal a tempered expectation for the stock's short-term performance. This mixed signal might lead to a neutral short-term impact on the stock price as investors weigh the positive rating against the lowered price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100